1466
N. Cos¸kun et al. / Tetrahedron: Asymmetry 12 (2001) 1463–1467
40.00; 52.82; 54.83; 57.98; 72.13; 77.96; 86.77; 111.51;
112.08; 112.48; 117.78; 125.71; 129.47; 129.36; 144.16;
145.02; 159.68. Anal. calcd for C27H34N2O2: C, 77.48;
H, 8.19; N, 6.69. Found: C, 77.44; H, 8.23; N, 6.66%.
115.30; 127.22; 135.5; 159.07. Anal. calcd for
C27H34N2O3: C, 74.62; H, 7.89; N, 6.45. Found: C,
74.50; H, 7.63; N, 6.45%.
3.9. 1,4-Di-p-methoxyphenylimidazole 4e
3.5. 4-m-Methoxyphenyl-1-p-tolyl-imidazole 4c
Obtained as the second product from the reaction
mixture of 3e. Yield 20%. Recrystallized from ethanol;
mp 158°C; IR (KBr) wCꢀN 1625 cm−1; 1H NMR
(CDCl3): l ppm 3.80 (3H, s), 3.84 (3H, s), 6.88 (2H, d,
J=8.69), 6.95 (2H, d, J=8.83), 7.30 (1H, s), 7.33 (2H,
s), 7.68 (1H, s), 7.70 (2H, s). 13C NMR (CDCl3): l ppm
55.41, 55.75; 113.34; 114.37; 115.24; 123.35; 126.52;
127.17; 131.24; 135.87; 143.43; 159.20; 159.25.
The compound was isolated from the mother liquor of
compound 3c as an oil. Yield 24%. IR (neat) wCꢀN 1625
1
cm−1. H NMR (CDCl3): l ppm 2.40 (3H, s), 3.86 (3H,
s), 6.46 (1H, d, J=8.35), 7.29 (6H, m), 7.39 (1H, s),
7.49 (1H, s), 7.81 (1H, s). 13C NMR (CDCl3): l ppm
21.43; 55.43; 110.25; 113.79; 117.69; 121.68; 129.85;
130.75; 137.64; 160.38.
3.6. Perhydroimidazoisoxazole 3d
3.10. Perhydroimidazoisoxazole 3f
The compound was purified by column chromatogra-
phy using silica gel as adsorbent and ethyl acetate–
petroleum ether (1:10) as eluent mixture. Yield 47%; mp
The reaction mixture was stirred under reflux in toluene
for 18 days. The product was purified by column
chromatography using silica gel as adsorbent and ethyl
acetate–petroleum ether as eluent. Yield 25%; mp 194–
195°C; [h]2D0=+80 (c=0.5, CHCl3);); 1H NMR
(CDCl3): l ppm 0.75 (3H, s), 1.17 (3H, s), 1.74 (1H, d,
J=10.14), 1.64 (1H, m), 1.82 (3H, m), 2.00 (1H, t,
J=4.70), 2.14 (3H, s), 2.45 (2H, JAB=12.51), 3.95 (2H,
1
115.5–117°C; [h]2D0=+93.75 (c=0.4, CHCl3); H NMR
(CDCl3): l ppm 0.84 (3H, s), 1.23 (3H, s), 1.50 (1H, d,
J=10.22), 1.71–1.90 (4H, m), 2.04 (1H, t, J=5.45), 2.14
(1H, s), 2.19–2.17 (1H, m), 2.34–2.42 (1H, m), 2.52–2.66
(1H, m), 3.5 (1H d, J=8.52), 3.63 (1H d, J=8.55), 3.69
(3H, s), 3.80 (3H, s), 4.3 (1H d, J=9.8), 4.55 (1H, d,
J=9.77), 6.43 (2H d, J=8.88), 6.71–6.77 (3H, m,),
6.94–7.03 (1H, m), 7.08–7.09 (1H, m), 7.17–7.25 (1H,
m). 13C NMR (CDCl3): l ppm 23.5; 24.84; 27.49; 31.12;
33.14; 38.99; 40.51; 53.26; 55.38; 55.97; 58.47; 59.46;
73.49; 78.67; 87.36; 111.94; 112.61; 114.21; 115.31;
118.31; 129.91; 141.48; 145.79; 152.44; 160.23. Anal.
calcd for C27H34N2O3: C, 74.62; H, 7.89; N, 6.45.
Found: C, 75.02; H, 7.78; N, 6.36%.
JAB=8.68), 5.50 (1H, s), 6.29 (2H, d, J=8.20), 6.91
(2H, d, J=8.20), 6.98 (6H, m), 7.08 (2H, m), 7.21 (2H,
d, J=5.76). 13C NMR (CDCl3): l ppm 22.73; 25.42;
26.86; 29.47; 36.11; 41.07; 42.51; 56.10; 60.56; 61.16;
87.86; 89.85; 98.58; 115.57; 128.45; 129.08; 129.62;
129.96; 130.07; 130.21; 131.92; 141.60; 144.95; 146.96.
Anal. calcd for C32H36N2O: C, 82.72; H, 7.81; N, 6.03.
Found: C, 82.34; H, 7.56; N, 5.86%.
3.11. Perhydroimidazoisoxazole 3g
3.7. 1-p-Methoxyphenyl-4-m-methoxyphenylimidazole
4d
Purification as for 3f 24%; mp 155.5–158°C; [h]2D0=
1
+97.7 (c=0.44, CHCl3); H NMR (CDCl3): l ppm 0.81
The product was isolated from the mother liquor of 3d
by flash column chromatography. Yields 41%. Recrys-
tallized from ethanol; mp 82-82.5°C; IR (KBr) wCꢀN
(3H, s), 1.23 (3H, s), 1.56 (1H, d, J=10.25), 1.71 (1H,
m), 1.85 (3H, m), 2.11 (1H, t, J=4.97), 2.20 (1H, m),
2.37 (1H, m) 2.44 (2H, JAB=12.55), 3.69 (3H, s), 4.03
(2H, JAB=8.57), 5.54 (1H, s), 6.39 (2H, d, J=8.97),
6.73 (2H, d, J=8.97), 6.72–7.00 (6H, m), 7.20 (2H, m),
7.33 (2H, m). Anal. calcd for C32H36N2O2: C, 79.96; H,
1
1625 cm−1; H NMR (CDCl3): l ppm 3.82 (3H, s), 3.85
(3H, s), 6.78 (1H, d, J=9.33), 6.95 (2H, d, J=8.75),
7.24–7.35 (4H, m), 7.41 (1H, s), 7.44 (1H, s), 7.74 (1H,
s). 13C NMR (CDCl3): l ppm 55.54; 55.81; 110.27;
113.63; 114.83; 115.30; 117.72; 123.40; 129.93; 130.98;
135.68; 136.14; 143.24; 159.38; 160.40. Anal. calcd for
C17H16N2O2: C, 72.84; H, 5.75; N, 9.99. Found: C,
71.93; H, 6.00; N, 9.85%.
7.55; N, 5.83. Found: C, 79.84; H, 7.51; N, 5.85 m/z:
+
480.3 (M , 10.83), 327.2 (4.66), 262.1 (4.1), 225.1 (100),
211.1 (12.33), 193.1 (7.94), 165.1 (2.36), 134.1 (23.76),
121.1 (10.95), 104.1 (8.56), 77.0 (5.49), 69.1 (1.99), 41.0
(2.63).
3.8. Perhydroimidazoisoxazole 3e
3.12. Retro-cycloaddition of perhydroimidazoisoxazoles
in condensed phase: general procedure for preparation
of 3f and 3g
Yield 55%; mp 140–140.7°C; [h]2D0=+100 (c=0.4,
1
CHCl3); H NMR (CDCl3): l ppm 0.85 (3H, s), 1.23
(3H, s), 1.50 (1H, d, J=10.24), 1.69–1.76 (1H, m),
1.83–1.91 (2H, m), 2.03 (1H, t, J=5.44), 2.14 (3H, s),
2.36–2.43 (1H, m), 2.54 (2H, JAB=12.54, 12.52), 3.57
(2H, JAB=8.57, 8.52), 3.71 (3H, s), 3.77 (3H, s), 4.26
(1H, d, J=9.85), 4.51 (1H, d, J=9.85), 6.42 (2H, d,
J=8.81), 6.74 (2H, d, J=8.93), 6.81 (2H, d, J=8.77),
7.34 (2H, d, 8.76). 13C NMR (CDCl3): l ppm 23.50;
24.88; 27.50; 31.12; 33.48; 39.01; 40.55; 53.36; 55.40;
55.97; 58.47; 58.78; 73.10; 78.32; 87.24; 113.96; 114.29;
Compound 3 (0.1 mmol) was placed in a glass sample
vial and heated in a vacuum oven at 200°C for 1 h at
1.3×10−3 mmHg and left to cool at room temperature.
The obtained 4 was extracted with warm hexane (3×2
mL). The extract was concentrated and cooled. The
formed crystals were collected by filtration. The identity
of the obtained imidazoles was determined comparing
their melting points as well as their IR spectra with
those of the authentic samples.